Thyroid disorder — all decisions

The Board denied the veteran's claim for an effective date prior to August 10, 2022, for service connection for hypothyroidism.

The Board denied a rating in excess of 40 percent for bilateral hearing loss and a rating in excess of 10 percent for tinnitus. The claims for service connection for various disabilities, including psychiatric conditions, lumbosacral spine disability, sleep apnea, pulmonary disease, esophageal issues, ulcers, intestinal problems, thyroid disorders, vertigo, headaches, TDIU, and special monthly compensation were remanded.

The Board denied an initial compensable rating for thyroid cancer, status post thyroidectomy with residual hypothyroidism and hypoparathyroidism, but granted an effective date of November 19, 2021, for the award of service connection.

The Board denied service connection for hearing loss and tinnitus, as well as remanded claims for hepatitis, diabetes mellitus, prostate condition, thyroid condition, and erectile dysfunction.

The Board dismissed all appeals as the Veteran did not submit a valid Notice of Disagreement (NOD) for each appeal.

The Board remands the claims for service connection for type 2 diabetes mellitus, hypertension, and hypothyroidism to verify exposure to herbicide agents in the Korean DMZ and obtain additional medical opinions.

The Board denied service connection for a back condition, hypercholesterolemia, an acquired psychiatric condition (PTSD, fear of water, and fear of heights), asthma, left upper extremity carpal tunnel syndrome, right upper extremity carpal tunnel syndrome, and hypothyroidism.

The Board denied service connection for various conditions, including Graves' disease, hysterectomy, hypothyroidism, loss of smell, bilateral hearing loss, anxiety and depression, and vision condition.

The Board granted service connection for hypothyroidism based on the presumption that it was chronic during active service.

The Board remands the claims for service connection for thyroid and cervical spine disabilities to correct duty to assist errors that occurred prior to the August 2021 rating decision on appeal.

The Board denied the Veteran's August 2023 Application for Disability Compensation and Related Compensation Benefits (VA Form 21-526EZ) as it was the incorrect form to file when seeking to reopen previously denied claimed disorders.

The appeal for service connection for hypothyroidism was dismissed as the Veteran did not withdraw his request for higher-level review, and the benefit sought on appeal had already been granted. The appeal for service connection for bilateral hip pain (osteoarthritis) was remanded for further development.

The Board denied service connection for thyroid nodules, soft tissue sarcoma, and lymphoma, all claimed as due to Agent Orange exposure during the Veteran's service in Vietnam.

The Veteran's service-connected ischemic heart disease was granted a 30 percent increased disability evaluation, effective May 8, 2022. Service connection for hypothyroidism and a compensable rating for hypertension were denied.

The Board remands the claim for a VA endocrinological examination to address the medical treatises submitted by the Veteran in July 2021 and ensure compliance with previous remand instructions.

The Board remands the case for a new and adequate VA examination to correct a duty to assist error on the part of the originating agency in satisfying its duties under 38 U.S.C. § 5103A.

The Board denied an increased rating for coronary artery disease and a compensable rating for hypertension, while remanding the claim for hypothyroidism.

The Veteran withdrew his appeals for service connection for thyroid cancer, nerves (claimed as anxiety/mood swings), and sleep apnea.

The Board denied service connection for vitamin D deficiency and denied higher ratings for irritable bowel syndrome, palpitations/sinus tachycardia, and hyperthyroidism. However, a 20 percent rating was granted from May 19, 2024, to August 28, 2024, for IBS, and a 30 percent rating was granted from September 5, 2023, for palpitations/sinus tachycardia.

The Board remands the claims for service connection for residuals of thyroid cancer and multiple sclerosis (also claimed as chronic dizzy spells) to obtain additional medical evidence.